Top news of the week: 04.08.2020.
Biotechnology, Microbiology, Medicine, Malaria, Vaccination, OTC Bulletin Board
Healthcare
Vaccines typically take years, if not decades, to reach people. @DrewQJoseph explains what has propelled efforts on #COVID19 so far:
🚩A familiar family
🚩Cutting-edge approaches
🚩Regulatory collaboration
🚩Resource mobilization
https://t.co/XocbDr7DTM https://t.co/spszUgYv2Y
Open‘A huge experiment’: How the world made so much progress on a Covid-19 vaccine so fast
The coronavirus is an easier target for potential vaccines than other pathogens, and a prime candidate for new cutting-edge vaccine platforms.
RT @antonioregalado: "Off the charts looney" or the best chance at immunity?
We report on a DIY nasal coronavirus vaccine making the rounds among early-adopters in Boston.
https://t.co/HQDqsO3jns
OpenSome scientists are taking a DIY coronavirus vaccine, and nobody knows if it’s legal or if it works
Preston Estep was alone in a borrowed laboratory, somewhere in Boston. No big company, no board meetings, no billion-dollar payout from Operation Warp Speed, the US government’s covid-19 ...
RT @matthewherper: Brigham president resigns from Moderna board after conflict of interest questions raised https://t.co/5YUMFazjmC
OpenBrigham president resigns from Moderna board after conflict of interest questions raised
Dr. Elizabeth Nabel's hospital is participating in the Cambridge biotech's trial of a COVID-19 vaccine. She recently sold stock in it worth nearly $6.5m.
RT @Africadisruptiv: Innovation Supports Growth at Big Pharma/Big Biotech Companies - https://t.co/be7TGtUGs3 https://t.co/G7qYVvn2OQ
OpenInnovation Supports Growth at Big Pharma/Big Biotech Companies
Moats and returns on invested capital look stable for companies with a solid list of pipeline drugs.
RT @BioStocks: The Week Ahead In #Biotech + earnings schedule.
$NVAX $TRVN $DBVT $EGRX $BSGM
https://t.co/4Cew1s2x0S
OpenThe Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in,...
For biotechs, collaboration is key to successful innovation #BioTech via https://t.co/2sI0UxrA0N https://t.co/XaBm2WsiZO
OpenCell and gene therapies: For biotechs, collaboration is key to successful innovation
With the right partner, biotech companies can fully embrace cell and gene therapy opportunities.
Penny Stocks To Watch As Biotech Takes Center Stage In 2020 #BioTechnology #biotech via https://t.co/2sI0UxJbpn https://t.co/1HppJb6qma
OpenPenny Stocks To Watch As Biotech Takes Center Stage In 2020
Biotech Penny Stocks To Watch This Month
FDA Approves Monjuvi® (tafasitamab-cxix) in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma $incy https://t.co/rMfeS0muxo
OpenFDA Approves Monjuvi® (tafasitamab-cxix) in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
FDA Approves Monjuvi® (tafasitamab-cxix) in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory DLBCL